Gardasil 9 SDV 10X0.5ml(9) (HPV VACCINE 9-VALENT/PF)

Reference priceJPY ¥5,749.63Original source price: INR 3,285.50. Converted estimates are available by currency selection.

Brand	Gardasil
Manufacturer	MERCK & CO/USHH PDP
Prescription required	Yes

Description

Gardasil 9 SDV 10X0.5ml(9) (HPV VACCINE 9-VALENT/PF) is a medicine catalog record in the MediPriceHub database. Active ingredient: HPV VACCINE 9-VALENT/PF. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: MERCK & CO/USHH PDP. Therapeutic category: Medicine Library > Oncology Medicines > Head and Neck Cell Carcinoma. Pack information: 10 X0.5. Origin country or market: United States. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.

Benefits

GARDASIL 9 is a vaccine indicated in girls and women 9 through 45 years of age for the prevention of the following diseases: And the following precancerous or dysplastic lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58: GARDASIL 9 is indicated in boys and men 9 through 45 years of age for the prevention of the following diseases: And the following precancerous or dysplastic lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58: The oropharyngeal and head and neck cancer indication is approved under accelerated approval based on effectiveness in preventing HPV- related anogenital disease. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial . Limitations of Use and Effectiveness: Cervical, vulvar, vaginal, anal, oropharyngeal and other head and neck cancers caused by Human Papillomavirus (HPV) types 16, 18, 31, 33, 45, 52, and 58. Genital warts (condyloma acuminata) caused by HPV types 6 and 11. Cervical intraepithelial neoplasia (CIN) grade 2/3 and cervical adenocarcinoma in situ (AIS). Cervical intraepithelial neoplasia (CIN) grade 1. Vulvar intraepithelial neoplasia (VIN) grade 2 and grade 3. Vaginal intraepithelial neoplasia (VaIN) grade 2 and grade 3. Anal intraepithelial neoplasia (AIN) grades 1, 2, and 3. Anal, oropharyngeal and other head and neck cancers caused by HPV types 16, 18, 31, 33, 45, 52, and 58. Genital warts (condyloma acuminata) caused by HPV types 6 and 11. Anal intraepithelial neoplasia (AIN) grades 1, 2, and 3. Vaccination with GARDASIL 9 does not eliminate the necessity for vaccine recipients to undergo screening for cervical, vulvar, vaginal, anal, oropharyngeal and other head and neck cancers as recommended by a health care provider. G

How to Use

Use HPV VACCINE 9-VALENT/PF under the supervision of a qualified healthcare professional. Use it only according to the approved label and the instructions of a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.

Specification

Active ingredient: HPV VACCINE 9-VALENT/PF. Pack size: 10 X0.5. Pack unit: box. Manufacturer: MERCK & CO/USHH PDP. Origin country: United States. Source category: Medicine Library > Oncology Medicines > Head and Neck Cell Carcinoma. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.

Side Effects

Cancer medicines may cause fatigue, nausea, vomiting, diarrhea or constipation, appetite changes, mouth sores, rash, changes in blood counts, infection risk, liver or kidney test changes, bleeding risk, neuropathy, infusion reactions, or organ-specific toxicity depending on the medicine. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, confusion, serious bleeding, signs of infection, or rapidly worsening symptoms. The approved local prescribing information is the controlling source for the complete adverse-reaction profile.

この情報は参考情報です。医薬品を使用する前に医療専門家へご相談ください。